文献速递流行病学与生物统计临床试验与 GCP

细菌学阴性疑似结核患者启动抗结核治疗相关因素:个体患者数据Meta分析

Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
PubMed 文献 · PLoS Med · 2025-01-13

全球超过三分之一的肺结核诊断是在细菌学检测阴性后依据临床标准作出的。本研究系统检索2010年1月至2022年12月的研究,纳入常规诊疗中接受结核评估且初次细菌学检测阴性后随访至少1周的试验或队列研究,采用分层贝叶斯logistic回归分析启动治疗的相关因素。

要点

  • 男性、既往结核史、咳嗽、盗汗及HIV感染未接受抗病毒治疗与启动结核治疗正相关。
  • Xpert阴性者较涂片镜检阴性者启动治疗的可能性更低(aOR 0.77)。
  • 近年启动结核治疗的可能性下降,原文未报告原因数据。

核心结论

  • 多种因素影响细菌学检测阴性后启动结核治疗的决定。
  • 使用更敏感的PCR类诊断且结果阴性时,临床医生启动治疗的可能性明显更低。

研究设计与样本

  • 系统综述与个体患者数据Meta分析,检索2010年1月至2022年12月发表的研究(PROSPERO注册号CRD42022287613)。
  • 纳入常规诊疗环境中接受结核评估、依据临床检查与常规诊断方法评估并在初次检测结果后随访至少1周的试验或队列研究。
  • 采用分层贝叶斯logistic回归分析初次细菌学检测阴性后启动治疗的相关因素。

主要发现

  • 男性与启动治疗正相关(aOR 1.61,95%CI 1.31–1.95)。
  • 既往结核史与启动治疗正相关(aOR 1.36,95%CI 1.06–1.73)。
  • 报告咳嗽与启动治疗正相关(aOR 4.62,95%CI 3.42–6.27),报告盗汗与启动治疗正相关(aOR 1.50,95%CI 1.21–1.90)。
  • HIV感染但未接受抗逆转录病毒治疗与启动治疗正相关(aOR 1.68,95%CI 1.23–2.32)。
  • Xpert检测阴性者较涂片镜检阴性者启动治疗的可能性更低(aOR 0.77,95%CI 0.62–0.96),且启动治疗的可能性随近年下降。

局限性

  • 原文指出无法评估临床医生作出治疗决定的原因,因为相关数据不可获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Globally, over one-third of pulmonary tuberculosis (TB) disease diagnoses are made based on clinical criteria after a negative bacteriological test result. There is limited information on the factors that determine clinicians' decisions to initiate TB treatment when initial bacteriological test results are negative. METHODS AND FINDINGS: We performed a systematic review and individual patient data meta-analysis using studies conducted between January 2010 and December 2022 (PROSPERO: CRD42022287613). We included trials or cohort studies that enrolled individuals evaluated for TB in routine settings. In these studies, participants were evaluated based on clinical examination and routinely used diagnostics and were followed for ≥1 week after the initial test result. We used hierarchical Bayesian logistic regression to identify factors associated with treatment initiation following a negative result on an initial bacteriological test (e.g., sputum smear microscopy (SSM), Xpert MTB/RIF). Multiple factors were positively associated with treatment initiation: male sex [adjusted odds ratio (aOR) 1.61 (1.31, 1.95)], history of prior TB [aOR 1.36 (1.06, 1.73)], reported cough [aOR 4.62 (3.42, 6.27)], reported night sweats [aOR 1.50 (1.21, 1.90)], and having HIV infection but not on ART [aOR 1.68 (1.23, 2.32)]. Treatment initiation was substantially less likely for individuals testing negative with Xpert [aOR 0.77 (0.62, 0.96)] compared to smear microscopy and declined in more recent years. We were not able assess why clinicians made treatment decisions, as these data were not available. CONCLUSIONS: Multiple factors influenced decisions to initiate TB treatment despite negative test results. Clinicians were substantially less likely to treat in the absence of a positive test result when using more sensitive, PCR-based diagnostics.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Kim S, Can MH, Agizew TB, et al. Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis. PLoS Med. 2025. PMID: 39804959. doi:10.1371/journal.pmed.1004502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。